Paraquat increases connective tissue growth factor and collagen expression via angiotensin signaling pathway in human lung fibroblasts

Toxicology in Vitro

Volumn 24, Issue 3, 2010, Pages 803-808

  Tung, Jai Nien ^a   Lang, Yaw Dong ^b   Wang, Leng Fang ^c   Chen, Chung Ming ^b  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiotensin; Collagen; Connective tissue growth factor; Saralasin

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; PARAQUAT; SARALASIN;

ARTICLE; COLLAGEN SYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOTTING, WESTERN; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE II; CONNECTIVE TISSUE GROWTH FACTOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; HERBICIDES; HUMANS; PARAQUAT; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARALASIN; SIGNAL TRANSDUCTION;

EID: 77649181496     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.12.015     Document Type: Article

References (27)

1. Bogatkevich G.S., Ludwicka-Bradley A., Singleton C.B., Bethard J.R., and Silver R.M. Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration. American Journal of Physiology 295 (2008) L603-L611
2. Bonniaud P., Margetts P.J., Kolb M., Haberberger T., Kelly M., Robertson J., and Gauldie J. Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. American Journal of Respiratory and Critical Care Medicine 168 (2003) 770-778
3. Chen C.M., and Lua A.C. Lung toxicity of paraquat in the rat. Journal of Toxicology and Environmental Health A 60 (2000) 477-487
4. Chen C.M., Chou H.C., Hsu H.H., and Wang L.F. Transforming growth factor-beta1 upregulation is independent of angiotensin in paraquat-induced lung fibrosis. Toxicology 216 (2005) 181-187
5. Chen C.M., Wang L.F., Chou H.C., Lan Y.D., and Lai Y.P. Up-regulation of connective tissue growth factor in hyperoxia-induced lung fibrosis. Pediatric Research 62 (2007) 128-133
6. Chesnutt A.N., Matthay M.A., Tibayan F.A., and Clark J.G. Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. American Journal of Respiratory and Critical Care Medicine 156 (1997) 840-845
7. Davis L.K., Rodgers B.D., and Kelley K.M. Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line. Endocrine 33 (2008) 32-39
8. DeGasparo M., Catt K.J., Inagami T., Wright J.W., and Unger T. International Union of Pharmacology XXIII. The angiotensin II receptors. Pharmacological Reviews 52 (2000) 415-472
9. Dinis-Oliveira R.J., Duarte J.A., Sánchez-Navarro A., Remião F., Bastos M.L., and Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Critical Reviews in Toxicology 38 (2008) 13-71
10. Filippatos G., Tilak M., Pinillos H., and Uhal B.D. Regulation of apoptosis by angiotensin II in the heart and lungs. International Journal of Molecular Medicine 7 (2001) 273-280
11. Finckenberg P., Inkinen K., Ahonen J., Merasto S., Louhelainen M., Vapaatalo H., Muller D., Ganten D., Luft F., and Mervaala E. Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. American Journal of Pathology 163 (2003) 355-366
12. Huang Z., Taylor L., Liu B., Yu J., and Polgar P. Modulation by bradykinin of angiotensin type 1 receptor-evoked RhoA activation of connective tissue growth factor expression in human lung fibroblasts. American Journal of Physiology 290 (2006) L1291-L1299
13. Iwanciw D., Rehm M., Porst M., and Goppelt-Struebe M. Induction of connective tissue growth factor by angiotensin II: integration of signaling pathways. Arteriosclerosis, Thrombosis, and Vascular Biology 23 (2003) 1782-1787
14. Kirk J.M., Heard B.E., Kerr I., Turner-Warwick M., and Laurent G.J. Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis. Collagen and Related Research 4 (1984) 169-182
15. Lasky J.A., Ortiz L.A., Tonthat B., Hoyle G.W., Corti M., Athas G., Lungarella G., Brody A., and Friedman M. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. American Journal of Physiology 275 (1998) L365-L371
16. Liebler J.M., Qu Z., Buckner B., Powers M.R., and Rosenbaum J.T. Fibroproliferation and mast cells in the acute respiratory distress syndrome. Thorax 53 (1998) 823-829
17. Marshall R.P., Bellingan G., Webb S., Puddicombe A., Goldsack N., McAnulty R.J., and Laurent G.J. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. American Journal of Respiratory and Critical Care Medicine 162 (2000) 1783-1788
18. Marshall R.P., Gohlke P., Chambers R.C., Howell D.C., Bottoms S.E., Unger T., McAnulty R.J., and Laurent G.J. Angiotensin II and the fibroproliferative response to acute lung injury. American Journal of Physiology 286 (2004) L156-L164
19. Meduri G.U., Tolley E.A., Chinn A., Stentz F., and Postlethwaite A. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. American Journal of Respiratory and Critical Care Medicine 158 (1998) 1432-1441
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65 (1983) 55-63
21. Moussad E.E., and Brigstock D.R. Connective tissue growth factor: what's in a name?. Molecular Genetics and Metabolism 71 (2000) 276-292
22. Otsuka M., Takahashi H., Shiratori M., Chiba H., and Abe S. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Thorax 59 (2004) 31-38
23. Rocco P.R.M., Negri E.M., Kurtz P.M., Vasconcellos F.P., Silva G.H., Capelozzi V.L., Romero P.V., and Zin W.A. Lung tissue mechanics and extracellular matrix in acute lung injury. American Journal of Respiratory and Critical Care Medicine 164 (2001) 1067-1071
24. Rupérez M., Ruiz-Ortega M., Esteban V., Lorenzo O., Mezzano S., Plaza J.J., and Egido J. Angiotensin II increases connective tissue growth factor in the kidney. American Journal of Pathology 163 (2003) 1937-1947
25. Sato S., Nagaoka T., Hasegawa M., Tamatani T., Nakanishi T., Tagikawa M., and Takehara K. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Journal of Rheumatology 27 (2000) 149-154
26. Satoh T., and Hosokawa M. Organophosphates and their impact on the global environment. Neurotoxicology 21 (2000) 223-227
27. Yamashita M., Yamashita M., and Ando Y. A long-term follow-up of lung function in survivors of paraquat poisoning. Human and Experimental Toxicology 19 (2000) 99-103